Researchers identify a potentially effective treatment for methamphetamine addiction

May 19, 2015
Lara Ray is the associate professor of psychology at UCLA, director of the UCLA Addictions Laboratory and lead author of the new study. Credit: Reed Hutchinson/UCLA

A new study by UCLA researchers has found that Naltrexone, a drug used to treat alcoholism, may also be a promising treatment for addiction to methamphetamine.

"The results were about as good as you could hope for," said Lara Ray, a UCLA associate professor of psychology, director of the UCLA Addictions Laboratory and lead author of the new study.

The study, published in the journal Neuropsychopharmacology, was the first in the U.S. to evaluate Naltrexone for treating addiction. Researchers analyzed 22 men and eight women who use methamphetamine an average of three to four days a week.

During a four-day hospital stay, each person was each given either Naltrexone—25 milligrams the first two days, 50 milligrams on days three and four—or a placebo daily. Ten days later, the subjects were readmitted to the hospital for four more days; those who had taken Naltrexone earlier were given placebos, and vice versa.

On the last day of each hospital visit, all participants were given intravenous doses of methamphetamine. Three hours later, the researchers asked how they felt and how much they wanted more of the drug.

The scientists found that Naltrexone significantly reduced the subjects' craving for methamphetamine, and that it made them less aroused by methamphetamine: Subjects' heart rates and pulse readings both were significantly higher when they were given the placebo than when they took Naltrexone. In addition, participants taking Naltrexone had lower and pulses when they were presented with their drug paraphernalia than those who were given placebos.

Ray said the results indicated that Naltrexone reduced the rewarding effects of the drug—those taking Naltrexone did not find methamphetamine to be as pleasurable and were much less likely to want more of it.

Naltrexone was well tolerated and had very minimal side effects. The researchers found that men and women both were helped by taking Naltrexone, although the positive effect on men was slightly smaller. It made no difference whether the participants were given Naltrexone during their first hospital stay or their second.

Naltrexone works by blocking opioid receptors in the brain. Ray said that in previous studies, people undergoing treatment for alcoholism reported getting less of a "high" from drinking when they take Naltrexone.

Ray, whose research team studies the causes of drug and alcohol addiction and possible treatments, plans to examine whether Naltrexone would be more effective in combination with other pharmaceuticals and at different doses. Her research is funded by the National Institute on Drug Abuse and UCLA's Clinical and Translational Science Institute.

Twenty-five of the participants also underwent functional magnetic resonance imaging, or fMRI, brain scans in UCLA's Center for Cognitive Neuroscience. Ray and UCLA graduate student Kelly Courtney, a co-author of the Neuropsychoparmacology paper, are analyzing that data.

Methamphetamine use disorder is a serious psychiatric condition that can cause psychosis and brain damage, and for which no FDA-approved medication exists. An estimated 12 million Americans have used methamphetamine, nearly 400,000 of whom are addicted to it, according to recent estimates.

Although the new study is promising, it needs to be backed up by clinical trials, said Ray, who is also a member of the UCLA Brain Research Institute. The next step in evaluating Naltrexone's effectiveness for treating people addicted to methamphetamine is already underway: the National Institute on Drug Abuse is sponsoring clinical trials.

Explore further: Asians fighting alcoholism may benefit from new study

Related Stories

Asians fighting alcoholism may benefit from new study

September 27, 2011
(Medical Xpress) -- New UCLA psychology research indicates that Asians who are struggling with alcoholism may benefit especially from naltrexone, one of three medications approved by the U.S. Food and Drug Administration ...

Naltrexone linked to reduction in pain in fibromyalgia

February 12, 2013
(HealthDay)—Low-dose naltrexone treatment is associated with significant reductions in pain in patients with fibromyalgia, according to a study published in the February issue of Arthritis & Rheumatism.

New study details how cocaine really works in the brain, suggests possibile addiction treatment

February 4, 2015
A research team led by the University of Colorado Boulder has discovered a mechanism in the brain that is key to making cocaine seem pleasurable, a finding that could lead to a drug treatment for fighting addiction.

Opioid relapse rates fall after jail release, according to pilot study

April 14, 2015
It has been called a pioneering strategy for treating opioid addiction, and has already been adopted in a small yet growing number of jails and prisons in the United States. Now, a clinical trial published in the journal ...

Study sheds light on pain pill abuse

September 26, 2012
A study by a team of University of Kentucky researchers has shed new light on the potential habit-forming properties of the popular pain medication tramadol, in research funded by the National Institute on Drug Abuse. The ...

Nalmefene for alcohol dependence: Added benefit not proven

December 4, 2014
Nalmefene (trade name Selincro) has been approved since February 2013 for people with alcohol dependence who currently drink a lot of alcohol, but who do not have physical withdrawal symptoms and who do not require immediate ...

Recommended for you

Study finds medical cannabis is effective at reducing opioid addiction

November 17, 2017
A new study conducted by researchers at The University of New Mexico, involving medical cannabis and prescription opioid use among chronic pain patients, found a distinct connection between having the legal ability to use ...

Insomnia linked to alcohol-use frequency among early adolescents, says new psychology study

November 8, 2017
Insomnia is linked to frequency of alcohol use among early adolescents, according to new Rutgers University–Camden research.

Large declines seen in teen substance abuse, delinquency

October 25, 2017
More than a decade of data indicates teens have become far less likely to abuse alcohol, nicotine and illicit drugs, and they also are less likely to engage in delinquent behaviors, such as fighting and stealing, according ...

Trying to get sober? NIH offers tool to help find good care

October 3, 2017
The phone calls come—from fellow scientists and desperate strangers—with a single question for the alcohol chief at the National Institutes of Health: Where can my loved one find good care to get sober?

Medical students need training to prescribe medical marijuana

September 15, 2017
Although 29 states and the District of Columbia allow marijuana use for medical purposes, few medical students are being trained how to prescribe the drug. Researchers at Washington University School of Medicine in St. Louis ...

Protein links alcohol abuse and changes in brain's reward center

September 8, 2017
When given access to alcohol, over time mice develop a pattern similar to what we would call "problem drinking" in people, but the brain mechanisms that drive this shift have been unclear. Now a team of UC San Francisco researchers ...

3 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

AddictionMyth
1 / 5 (1) May 19, 2015
Wow this is a really dumb idea. No meth 'addict' would choose to get a drug that prevents them from enjoying it. That's the whole point in taking it in the first place. Unless the goal is coerced Vivitroll (extend release naltrexone) which is a horrible idea. It has very uncomfortable side effects (including severe complications in emergency/surgery) and people are ready to blow their brains out after a few months on it. Suicide rate is far worse than meth!
TogetherinParis
not rated yet May 20, 2015
Non-alcoholic heroin addiction is cured by oral intake of 1/4 gram of healthy adult male facial skin surface lipid pheromone.
Non-alcoholic cocaine addiction is cured by oral intake of 1/4 gram of healthy adult male facial skin surface lipid pheromone.
Non-alcoholic oxycodone addiction is cured by oral intake of 1/4 gram of healthy adult male facial skin surface lipid pheromone.
SusejDog
not rated yet Jun 17, 2015
The fact of the matter remains that most users who need to use meth legitimately as a drug in reasonable doses for weight loss or ADHD are unable to do so for no good reason.

If I was running things, it along with its dextro version would be cheaply available OTC, and addicts would have the convenient option of using naltrexone to prevent or reverse their addiction at any time.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.